Hepatic impairment trial: ClinicalTrials.gov, NCT01790607 (https://clinicaltrials.gov/ct2/show/NCT01790607). Renal impairment trial: EudraCT Number: 2014-004575-23.

KI fragen

Bookmark

View Full Paper

KI fragen

Bookmark

View Full Paper

Cite This Study

Stöhr et al. (Thu,) studied this question.

synapsesocial.com/papers/69efcaa4daa5208b6cb0bb4f https://doi.org/https://doi.org/10.1016/j.bja.2021.05.027

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Perioperative Management of Patients With End-Stage Renal Disease2017 · 110 citations
2Prediction of Creatinine Clearance from Serum Creatinine2008 · 15,397 citations
3Relevance of Arteriovenous Concentration Differences in Pharmacokinetic-Pharmacodynamic Modeling of Midazolam1998 · 32 citations
4Likelihood based approaches to handling data below the quantification limit using NONMEM VI2008 · 332 citations
5Anaesthesia for patients with liver disease2009 · 65 citations

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Perioperative Management of Patients With End-Stage Renal Disease2017 · 110 citations
2Prediction of Creatinine Clearance from Serum Creatinine2008 · 15,397 citations
3Relevance of Arteriovenous Concentration Differences in Pharmacokinetic-Pharmacodynamic Modeling of Midazolam1998 · 32 citations
4Likelihood based approaches to handling data below the quantification limit using NONMEM VI2008 · 332 citations
5Anaesthesia for patients with liver disease2009 · 65 citations